Cargando…
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)
PURPOSE OF REVIEW: Reducing the risk of HIV-associated neurocognitive disorders (HAND) is an elusive treatment goal for people living with HIV. Combination antiretroviral therapy (cART) has reduced the prevalence of HIV-associated dementia, but milder, disabling HAND is an unmet challenge. As newer...
Autor principal: | Kolson, Dennis L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305687/ https://www.ncbi.nlm.nih.gov/pubmed/35867211 http://dx.doi.org/10.1007/s11904-022-00612-2 |
Ejemplares similares
-
Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals
por: Underwood, Jonathan, et al.
Publicado: (2016) -
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
por: Yilmaz, Aylin, et al.
Publicado: (2019) -
Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered
por: Gelman, Benjamin B.
Publicado: (2015) -
Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update
por: Nichols, Sharon L.
Publicado: (2022) -
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program
por: Riggs, Patricia K., et al.
Publicado: (2022)